Aligos Therapeutics and Metrion explore key approaches to cardiovascular safety screening in drug discovery.
Dr Gary Clark, Director of Screening, and Dr Eddy Stevens, CSO, speak with Dr Chris Mathes, CCO, about ion channel screening at Metrion. Dr Thomas Hill, Senior Scientist and Dr Catherine Hodgson, Senior Scientist give deeper insight into automated patch clamp, and sealing solutions on the Qube.
Aligos Therapeutics and Metrion explore key approaches to cardiovascular safety screening in drug discovery.
Academic case study on Nav1.9 as a drug target by Associate Professor David Bulmer (University of Cambridge). Overview of Metrion’s newly developed Nav1.9 screening assays by Metrion CSO, Dr. Eddy Stevens.